RELATED PRODUCTS NOT AVAILABLE
-
UNITED STATES
North America
South America
Europe
Middle East / Africa
Asia / Pacific
BD Nano™ 2nd Gen
Pen Needles
Redesigned with patients in mind
- Overview
- Products & Accessories
false
Reliability
More reliable subcutaneous injections across a range of injection forces, with an up to ~8x reduction in the risk of intramuscular injection vs other 4mm pen needles2,*
Comfort
Easier and more comfortable injections from start to finish1
Confidence
Supports patient confidence with the injection experience1
Compatibility
Compatible with widely used pen injector devices3
BD PentaPoint™ Comfort and EasyFlow™ Technology
Existing proven benefits of BD PentaPoint™ Comfort and EasyFlow™ Technology4,5
Notes
* Across recommended injection sites: abdomen, thigh, arm, buttock, pooled across gender and BMI
References
1. Whooley S, et al. Evaluating the User Performance and Experience with a Re-Engineered 4 mm x 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles. Diabetes Ther. 2019;10(2):697-712.
2. Rini C, et al. Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection.J Diabetes Sci Technol. 2019;13(3):533-545.
3. BD Compatibility Confirmation for Pen Needles and Pen Injector Manufacturers; Document Number: 149OTH-0004-20 Rev K Dated: 10 April 2019.
4. Hirsch L.,et al. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes. Journal of Diabetes Science and Technology. 2012;6(2):328-335
5. Aronson R et al. Insulin pen needles: Effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clinical Therapeutics. 2013;35(7):923-933.
Notes
* Across recommended injection sites: abdomen, thigh, arm, buttock, pooled across gender and BMI
References
1. Whooley S, et al. Evaluating the User Performance and Experience with a Re-Engineered 4 mm x 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles. Diabetes Ther. 2019;10(2):697-712.
2. Rini C, et al. Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection.J Diabetes Sci Technol. 2019;13(3):533-545.
3. BD Compatibility Confirmation for Pen Needles and Pen Injector Manufacturers; Document Number: 149OTH-0004-20 Rev K Dated: 10 April 2019.
4. Hirsch L.,et al. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes. Journal of Diabetes Science and Technology. 2012;6(2):328-335
5. Aronson R et al. Insulin pen needles: Effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clinical Therapeutics. 2013;35(7):923-933.
BD-10841
embecta, formerly part of BD. BD is the manufacturer of the advertised products.